Lovastatin

Peripheral Arterial Disease, Primary Hypercholesterolemia, Coronary Revascularization + 16 more
Treatment
20 Active Studies for Lovastatin

What is Lovastatin

LovastatinThe Generic name of this drug
Treatment SummaryLovastatin is a medication used to lower cholesterol levels and reduce the risk of cardiovascular disease. It is part of a class of drugs called statins, which work by blocking the enzyme that produces cholesterol in your liver. Lovastatin is generally well-tolerated, making it a popular choice for both adults and children. It is often prescribed after a cardiovascular event or for people with a moderate to high risk of developing CVD. Other medications in the statin class include atorvastatin, pravastatin, rosuvastatin, fluvastatin, and simvastatin. Studies have shown that
Mevacoris the brand name
image of different drug pills on a surface
Lovastatin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Mevacor
Lovastatin
1987
285

Effectiveness

How Lovastatin Affects PatientsLovastatin is a medication used to lower cholesterol levels. It reduces the amount of low-density lipoprotein (LDL) in the blood and increases levels of high-density lipoprotein (HDL), which can reduce the risk of developing cardiovascular disease. Clinical studies have found that taking lovastatin can reduce total cholesterol and LDL by 25-40%. However, taking lovastatin can also lead to muscle pain, tenderness or weakness, and in rare cases, even death. Taking lovastatin with other drugs such as fenofibrate, niacin, gemfibrozil, or cycl
How Lovastatin works in the bodyLovastatin works by blocking an enzyme that is important for producing cholesterol in the liver. This reduces the amount of cholesterol in the body and helps lower the risk of cardiovascular disease. It also has other effects on the body, including improving blood vessel function, stabilizing plaque in arteries, and reducing inflammation and oxidative stress. Lovastatin has also been linked to cancer prevention and treatment, by triggering cell death in certain cancer cells and increasing the expression of certain proteins that can help stop cancer growth.

When to interrupt dosage

The proposed portion of Lovastatin is reliant upon the determined condition, including Dyslipidemias, 1 year post-menarche and Cardiovascular Diseases. The extent of dosage fluctuates, based on the technique of delivery indicated in the table below.
Condition
Dosage
Administration
Heart Attack
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Cholesterol, LDL
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Diet
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Coronary Heart Disease
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Apolipoprotein
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Hypercholesterolemia
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Dyslipidemias
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Low-Density Lipoproteins
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Cardiovascular Diseases
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Hypertriglyceridemia
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
1 year post-menarche
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Coronary heart disease
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Angina, Unstable
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Coronary Artery Disease
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Low-Density Lipoproteins
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
total cholesterol increased
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Peripheral Arterial Disease
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Primary Hypercholesterolemia
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral
Coronary Revascularization
20.0 mg, 40.0 mg, , 10.0 mg, 60.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral

Warnings

Lovastatin has seven contraindications. For any of the conditions outlined in the following table, Lovastatin should not be consumed.Lovastatin Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Lovastatin may interact with Pulse Frequency
Liver Diseases
Do Not Combine
Breast Milk Production
Do Not Combine
Transaminases
Do Not Combine
Pulse Frequency
Do Not Combine
unexplained elevations of serum transaminases
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Lovastatin.
Common Lovastatin Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Lovastatin.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Lovastatin.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Lovastatin.
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Lovastatin.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Lovastatin.
Lovastatin Toxicity & Overdose RiskThe lethal dose of lovastatin is higher than 15 g/m2. Five people took up to 200 mg of the drug without any major side effects. Although some people have taken accidental overdoses of lovastatin, none of them experienced any symptoms and recovered without any long-term effects. Studies have indicated that lovastatin may increase the risk of liver cancer, lung tumors, stomach and thyroid tumors, and may cause testicular atrophy, reduced sperm production, and decreased fertility in males. There is no evidence that lovastatin is mutagenic.
image of a doctor in a lab doing drug, clinical research

Lovastatin Novel Uses: Which Conditions Have a Clinical Trial Featuring Lovastatin?

134 active trials are currently underway to assess the potency of Lovastatin in Coronary Artery Atherosclerosis, Heart Attack and Coronary Heart Disease management.
Condition
Clinical Trials
Trial Phases
Peripheral Arterial Disease
38 Actively Recruiting
Not Applicable, Phase 3, Phase 2, Phase 1, Early Phase 1, Phase 4
Apolipoprotein
0 Actively Recruiting
Hypercholesterolemia
2 Actively Recruiting
Phase 1, Phase 3
Hypertriglyceridemia
0 Actively Recruiting
Coronary Artery Disease
1 Actively Recruiting
Not Applicable
Angina, Unstable
2 Actively Recruiting
Not Applicable
Coronary Revascularization
1 Actively Recruiting
Phase 4
Coronary Heart Disease
8 Actively Recruiting
Not Applicable, Early Phase 1
Cholesterol, LDL
0 Actively Recruiting
Diet
5 Actively Recruiting
Not Applicable, Phase 1
Low-Density Lipoproteins
0 Actively Recruiting
Heart Attack
26 Actively Recruiting
Not Applicable, Phase 4, Phase 1, Phase 2, Early Phase 1, Phase 3
Coronary heart disease
0 Actively Recruiting
Primary Hypercholesterolemia
10 Actively Recruiting
Phase 3, Phase 2, Not Applicable
Dyslipidemias
1 Actively Recruiting
Phase 2
1 year post-menarche
0 Actively Recruiting
total cholesterol increased
0 Actively Recruiting
Low-Density Lipoproteins
0 Actively Recruiting
Cardiovascular Diseases
0 Actively Recruiting

Lovastatin Reviews: What are patients saying about Lovastatin?

5Patient Review
10/26/2018
Lovastatin for Changes Involving Fatty Deposits in the Blood Vessels
I've been taking this for a while now and it's really helped me. However, I recently developed scleroderma, which my doctor thinks might be caused by this medication. If anyone else has had a similar experience, please let me know.
5Patient Review
10/16/2020
Lovastatin for High Cholesterol
I don't think I'll be renewing my prescription for this pill. It doesn't agree with my stomach since they switched manufacturers, and I'm currently taking the generic teva 576 version.
4.3Patient Review
5/1/2014
Lovastatin for High Cholesterol
3.7Patient Review
9/28/2017
Lovastatin for High Cholesterol
After taking Lovastatin for a few months, I realized that the drug was causing me a lot of pain. I now wonder how long it will take to get out of my system. The side effects are really bad and this drug should be banned.
3.7Patient Review
8/8/2014
Lovastatin for Combined High Blood Cholesterol and Triglyceride Level
I experienced more frequent bowel movements and swelling in my lower extremities while taking this medication.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about lovastatin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What's the difference between statin and lovastatin?

"There are two types of statins, simvastatin and lovastatin. Simvastatin is more effective at lowering cholesterol levels, while lovastatin is reserved for drug combinations or if a patient has an undesirable reaction to simvastatin."

Answered by AI

Is lovastatin a blood thinner?

"Statin medications not only improve the cardiovascular system by working on the inner lining of blood vessels and the heart muscle, but they also have a side effect of decreasing the blood's clotting ability. This is generally seen as a beneficial side effect with no increased risk of internal bleeding."

Answered by AI

What is the difference between Crestor and lovastatin?

"Crestor is one of the most effective statins to improve cholesterol and is also available as a generic. It lowers cholesterol. Mevacor can improve cholesterol, but it is not as strong as other statin medicines."

Answered by AI

What is the side effect of lovastatin?

"Lovastatin can cause an allergic reaction that makes it hard to breathe or swallow. Other symptoms include swelling in your face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs."

Answered by AI

Clinical Trials for Lovastatin

Have you considered Lovastatin clinical trials? We made a collection of clinical trials featuring Lovastatin, we think they might fit your search criteria.
Have you considered Lovastatin clinical trials? We made a collection of clinical trials featuring Lovastatin, we think they might fit your search criteria.
Have you considered Lovastatin clinical trials? We made a collection of clinical trials featuring Lovastatin, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top